Home » Topics » Regulatory » Patents

Patents
RSS

Takeda discloses new agents for neurodegenerative disorders

Nov. 27, 1996

Lilly claims 5-HT7 antagonist for GI indications

Nov. 26, 1996

HMG-CoA reductase inhibitors for preventing second heart attack

Nov. 26, 1996

Neuregulin polypeptides described for treating retinal disorders

Nov. 26, 1996

Lilly claims new indication for olanzapine

Nov. 26, 1996

New use claimed for olanzapine

Nov. 26, 1996

Melatonin receptor ligands described by ADIR

Nov. 26, 1996

New retinoid-like compounds from BMS

Nov. 26, 1996

New NMDA antagonists described by Zeneca

Nov. 26, 1996

Asta Medica reports new PDE IV and PDE V inhibitors

Nov. 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...